A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

  1. Cejalvo, J.-M.
  2. Jacob, W.
  3. Fleitas Kanonnikoff, T.
  4. Felip, E.
  5. Navarro Mendivil, A.
  6. Martinez Garcia, M.
  7. Taus Garcia, A.
  8. Leighl, N.
  9. Lassen, U.
  10. Mau-Soerensen, M.
  11. Adessi, C.
  12. Michielin, F.
  13. James, I.
  14. Ceppi, M.
  15. Hasmann, M.
  16. Weisser, M.
  17. Cervantes, A.
Revista:
ESMO Open

ISSN: 2059-7029

Any de publicació: 2019

Volum: 4

Número: 4

Tipus: Article

DOI: 10.1136/ESMOOPEN-2019-000532 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus